Abstract
Drs. Reid and Storer report no conflicts of interest. Dr. Bhasin reports receiving research grant support from AbbVie, Transition Therapeutics, FPT, and Metro International Biotechnology, Inc. and has received consulting fees from OPKO Pharmaceuticals and POXEL, Inc, and has equity interest in FPT, LLC and Xyone Therapeutics.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
